| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |